E-Mail 'FDA OKs Gattex for Short Bowel Syndrome' To A Friend

Email a copy of 'FDA OKs Gattex for Short Bowel Syndrome' to a friend

* Required Field






Separate multiple entries with a comma. Maximum 5 entries.



Separate multiple entries with a comma. Maximum 5 entries.


E-Mail Image Verification

Loading ... Loading ...

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.

FDA OKs Gattex for Short Bowel Syndrome

(MedPage Today) — The FDA has approved teduglutide (Gattex) for use in patients with short bowel syndrome who require parenteral nutrition.